Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00631462 · ClinicalTrials.gov registry record · Phase 1

A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis

A Phase 1 study of Myelofibrosis, sponsored by TargeGen.

Completed
Registry status
Phase 1
Development phase
59
Enrollment target
6
Study locations

NCT00631462 is a Phase 1 study of Myelofibrosis that has completed, run by TargeGen. The registered enrollment target is 59 participants, below the 195-participant average among 61 other Myelofibrosis trials with a reported enrollment target (70% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00631462, a Phase 1 study of Myelofibrosis, has completed, sponsored by TargeGen.

COMPLETED
Registry status
Phase 1
Development phase
59 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to evaluate the safety and tolerability of orally administered TG101348 in patients with myelofibrosis.

Conditions Studied

Myelofibrosis

Interventions

  • DRUG TG101348

Study Locations (6)

California

  • UCSD Moores Cancer Center - San Diego
  • Stanford Comprehensive Cancer Center - Stanford

Massachusetts

  • Dana Farber Cancer Institute - Boston

Michigan

  • University of Michigan Comprehensive Cancer Center - Ann Arbor

Minnesota

  • Mayo Clinic, Rochester - Rochester

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2008-01
Est. Completion 2009-10
Phase Phase 1

Sponsor

TargeGen

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00631462

The ClinicalTrials.gov registry entry for NCT00631462 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 195-participant average among 61 other Myelofibrosis trials with a reported enrollment target (70% lower). The listed sponsor is TargeGen, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myelofibrosis appearing as the primary indexed condition, and to 1 intervention - of which TG101348 is the first listed.

NCT00631462 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Massachusetts, Michigan.

Frequently Asked Questions

What is clinical trial NCT00631462 about?

NCT00631462 is a clinical study titled "A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis". The purpose of this study is to evaluate the safety and tolerability of orally administered TG101348 in patients with myelofibrosis.

What is the current status of trial NCT00631462?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2008-01. Estimated completion is 2009-10.

What conditions does trial NCT00631462 study?

This clinical trial studies the following conditions: Myelofibrosis.

What interventions are being tested in trial NCT00631462?

The interventions under investigation include: TG101348 (DRUG).

Who is sponsoring clinical trial NCT00631462?

This trial is sponsored by TargeGen, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00631462 being conducted?

This trial has 6 study locations across California, Massachusetts, Michigan, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myelofibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myelofibrosis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.